bevantolol and Chorea Disorders

bevantolol has been researched along with Chorea Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Calopa, M; Ferré, A; Gamez, J; Huertas, O; Insa, R; Kulisevsky, J; McAllister, K; Muñoz, E; Reig, N; Scart-Grès, C1

Trials

1 trial(s) available for bevantolol and Chorea Disorders

ArticleYear
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease.
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:5

    Topics: Chorea; Double-Blind Method; Humans; Huntington Disease; Tetrabenazine; Treatment Outcome; Vesicular Monoamine Transport Proteins

2023